Cargando…
eEF2K—a new target in breast cancers with combined inactivation of p53 and PTEN
Extensive efforts have now characterized the somatic molecular alterations in human breast cancer (Cancer Genome Atlas Network, 2012; Stephens et al, 2012) and have led to a re-definition of the disease as a constellation of 10 distinct driver-based subtypes (IntClust subtypes) (Curtis et al, 2012)....
Autores principales: | Russnes, Hege G, Caldas, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287969/ https://www.ncbi.nlm.nih.gov/pubmed/25471453 http://dx.doi.org/10.15252/emmm.201404683 |
Ejemplares similares
-
Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative
breast cancer with dependency on eEF2K
por: Liu, Jeff C, et al.
Publicado: (2014) -
IGF2: The Achilles' heel of p53-deficiency?
por: Clermont, Frederic, et al.
Publicado: (2012) -
PI3K signaling in the locus coeruleus: a new molecular pathway for ADHD research
por: Darcq, Emmanuel, et al.
Publicado: (2015) -
Decoding the evolution of a breast cancer genome
por: Bedard, Philippe L, et al.
Publicado: (2010) -
p63 and FGFR: when development meets proliferation
por: Dotto, G Paolo
Publicado: (2012)